Avivo
Developer of a health-tech platform intended to make blood groups irrelevant for transfusion or organ transplant. The company's platform uses a proprietary technology that is a combination of two enzy...
Valuation
$0
Share Price
N/A
Total Raised
$3.2M
Last Round
N/A